Listed@ASX
Your go-to source for ASX IPO and listed company news, insights and analysis.
Listed@ASX Spring 2023 edition
November 2023
Welcome to the latest insights, news and profiles from the world of listed companies and IPOs.
The ASX listings team has been hard at work, working with industry leaders and listed companies to bring you interesting profiles, trends and updates impacting the sector and those looking to list.
Leah Weckert - leading a fresh vision for Coles
In our lead story, we speak to Leah Weckert, CEO of the Coles Group (ASX:COL) about her vision for the future of the iconic Australian Retailer.
Profile: Kiwi ingenuity behind ground-breaking Rett Syndrome treatment
Neuren Pharmaceuticals Limited ASX:NEU
2023 winner of the Australian Growth Company of the Year Award, in the Health and Sciences category - Neuren Pharmaceuticals is building on its success with Daybue securing approval for another important drug.
Video: Listed@ASX Interview: Getting to know Redox Limited ASX:RDX
Sasha Conoplia, Manager, Listings ASX spoke to Raimond Coneliano, CEO and Managing Director of Redox Limited, about the company's recent listing and plans for local and overseas markets.
Watching time: 7:12
Profiles and news
More insights
Standout year for listings on ASX
Growth in sole listings of New Zealand companies on ASX
Cyber security round table: Protecting the perimeter
For more information contact the ASX Listings team.
Cover story: Todd Barlow on the enduring nature of WHSP
Australians maintain fascination for investing
Video: Getting to know Opthea (ASX:OPT) - interview with Megan Baldwin
Get to know your cyber pulse
ESG reporting for small- and mid-cap companies
Kiwi conquers US power poles
Investors dig new mining investment model
Incitec Pivot standing with global agriculture and mining
ASX capital markets 2022 - a year in review
Video: Getting to know newly-listed company, LGI
Straker: New Zealand language tech pioneer succeeds globally
Growth in sole listings of New Zealand companies on ASX
ASX dual listing helps position TruScreen for long-term growth
Listed@ASX goes digital
Video: Getting to know Richard White of Wisetech Global
Profile: Catapult - software over hardware
Case Study: Cluey Learning - Online learning comes of age
Profile: Volpara - The heart of the matter
Insight: Five megatrends shaping Australian and global agriculture
Profile: Lynch Group Holdings focused on blossoming flower market
New Zealand: Trans-Tasman agritech sector set to flourish
Video: Getting to know GrainCorp Limited (ASX: GNC)
Insight: Five megatrends shaping Australian and global agriculture
Cover story: Carrie Hurihanganui - In the slipstream
Profile: Opthea Limited - Looking ahead
Case study: Future Generation Investment Company - A new approach to philanthropy
ESG Round Table: It's the way you write your name
Profile: Doctor Care Anywhere - Aussie market attracts health innovators
Cyber Security Round Table: Protecting the perimeter
Australian Clinical Labs (ASX: ACL)
Giri Tenneti speaks to Australian Clinical Labs CEO, Melinda McGrath.
Wisetech Global (ASX: WTC)
Giri Tenneti speaks to Richard White, Founder and CEO of Wisetech Global
Clarity Pharmaceuticals (ASX:CU6)
James Posnett speaks to Dr. Alan Taylor, Executive Chairman of Clarity Pharmaceuticals
Sign up for Listed@ASX
Your go-to source for ASX IPO and listed company news, insights and analysis - straight to your inbox three time a year.
Educational Webinars and Guides
Subscribe here to hear about upcoming educational events for listed companies and their advisors.
What's next?
For more information contact the ASX Listings team.
The views, opinions or recommendations of the author in this article are solely those of the author and do not in any way reflect the views, opinions, recommendations, of ASX Limited ABN 98 008 624 691 and its related bodies corporate (“ASX”). ASX makes no representation or warranty with respect to the accuracy, completeness or currency of the content. The content is for educational purposes only and does not constitute financial advice. Independent advice should be obtained from an Australian financial services licensee before making investment decisions. To the extent permitted by law, ASX excludes all liability for any loss or damage arising in any way due to or in connection with the publication of this article, including by way of negligence.
